NCT04213274: A trial that was reported late by R-Pharm Overseas, Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04213274 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 31, 2023 |
| Completion date | Aug. 31, 2023 |
| Required reporting date | Aug. 30, 2024, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Jan. 17, 2025 |
| Days late | None |